Search PubMedSearch

PubMed · 42648476

Histone H3K27ac spreads from enriched chromatin domains into neighboring regions upon loss of CTCF binding.

Abstract

Acetylation of histone H3 at lysine 27 (H3K27ac) is enriched at enhancers and highly transcribed genes. Our previous study showed that an H3K27ac-enriched chromatin domain expanded into neighboring regions following the deletion of CTCF-binding motifs flanking the domain. In this study, we explored the spreading of H3K27ac on a genome-wide scale by analyzing its distribution around CTCF-binding sites in human K562 cells and examining changes upon CTCF loss. We found that a subset of CTCF-binding sites demarcates H3K27ac-enriched domains. Upon loss of CTCF binding, H3K27ac levels increased in most regions adjacent to these domains, indicating that H3K27ac can spread into neighboring chromatin. This spreading was accompanied by elevated transcription of nearby genes. Chromatin features, including histone modifications, CTCF-binding intensity, and CTCF-mediated chromatin interactions, were associated with the H3K27ac spreading. Notably, enhancers were more enriched within domains that exhibited H3K27ac spreading compared to those that did not, and the deletion of enhancers from the CTCF motif-deficient β-globin locus attenuated the spreading. These findings indicate that CTCF-binding sites serve as boundaries for H3K27ac-enriched domains and that, in the absence of CTCF binding, H3K27ac can spread into neighboring regions. H3K27ac spreading appears to be influenced by multiple chromatin features and to contribute to the transcriptional increase of nearby genes.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Jin Kang, AeRi Kim. 2026-08-26. Histone H3K27ac spreads from enriched chromatin domains into neighboring regions upon loss of CTCF binding.. https://doi.org/10.1016/j.bbagrm.2026.195181

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Deciphering acquired resistance mechanisms to sustained auxin-inducible protein degradation in cells and mice.

Targeted protein degradation is a favorable strategy for studying the immediate downstream effects of protein loss-of-function. An appealing platform among these technologies is the auxin-inducible degron (AID) system. Although this system has been applied extensively to cell and animal models, degradation resistance to long-term auxin treatment has not been studied. With the advent of the new AID2 system, cellular toxicity due to the high concentrations of auxin required in the original AID1 system is no longer a concern, making it possible to study protein degradation over extended periods. In this study, we derived multiple miniAID-tagged knock-in human cell lines and a Ctcf-miniAID knock-in mouse strain to investigate mechanisms of degradation resistance. We revealed four independent resistance mechanisms, including a nonsense mutation in the CTCF coding sequence that removed the miniAID peptide, a missense point mutation in the miniAID coding region that disrupted ubiquitin complex targeting, and silencing of the OsTIR1 adaptor protein. Resistance to auxin degradation was also acquired in mouse primary CtcfminiAID/miniAID knock-in B-ALL cells through missense mutations of the OsTIR1(F74G) protein in vivo and ex vivo. In summary, our innovative study expands our understanding of the AID system and cautions careful consideration of design for future applications in mammalian system.

CTCF